LNTH250117P80000
- 0.70
- 0.000.00%
Lantheus Newsroom
Express News | Lantheus Holdings Inc - Revolving Line of Credit Increased to $750 Million
Express News | Lantheus Holdings Inc - Enters First Amendment to Credit Agreement
Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating
Lantheus (LNTH) Gets a Buy From Truist Financial
Will Weakness in Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Stock Prove Temporary Given Strong Fundamentals?
Lantheus Chief Medical Officer Humphrey Departs
Express News | Lantheus Holdings Inc - CEO Brian Markison and President Paul Blanchfield Assume Interim R&D Leadership
Express News | Lantheus Holdings Inc - Jeff Humphrey No Longer Cmo at Lantheus Holdings
P/E Ratio Insights for Lantheus Holdings
This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Lantheus Holdings Analyst Ratings
Goldman Sachs Initiates Lantheus(LNTH.US) With Buy Rating, Announces Target Price $143
Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Qiagen (QGEN)
Here's How Much You Would Have Made Owning Lantheus Holdings Stock In The Last 5 Years
Is Weakness In Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Why Lantheus Holdings, Inc. (LNTH) Is One of the Most Profitable Pharmaceutical Stocks Right Now
With EPS Growth And More, Lantheus Holdings (NASDAQ:LNTH) Makes An Interesting Case
Why Lantheus Holdings Stock Won Big on Wednesday
Express News | Lantheus Announces Share Repurchase Program
Lantheus Holdings Insider Sold Shares Worth $812,000, According to a Recent SEC Filing